Evolving role of cardiac transplantation for end-stage congestive heart failure

Transplantation Reviews

Volumn 19, Issue 1, 2005, Pages 40-46

  Pierson III, Richard N ^a   Johnson, Frances L ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIMITOTIC AGENT; AZATHIOPRINE; B LYMPHOCYTE ANTIBODY; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CD20 ANTIBODY; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID; RAPAMYCIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ANGINA PECTORIS; CARDIAC GRAFT REJECTION; CARDIOMYOPATHY; CHRONIC GRAFT REJECTION; CLINICAL PRACTICE; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; DONOR; DRUG MEGADOSE; GRAFT FAILURE; GRAFT SURVIVAL; HEALTH CARE POLICY; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEART TUMOR; HEPATITIS B; HEPATITIS C; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL ETHICS; MYOPATHY; OXYGEN CONSUMPTION; PATIENT SELECTION; PLASMAPHERESIS; QUALITY OF LIFE; RECIPIENT; REVIEW; SAFETY; SURGICAL RISK; THROMBOEMBOLISM; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TRICUSPID VALVE DISEASE;

EID: 17444376831     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2004.10.003     Document Type: Article

References (53)

1. J.D. Hardy C.M. Chavez F.E. Kurrus et al. Heart transplantation in man: developmental studies and report of a case JAMA 188 1964 1132
2. C.N. Barnard The operation. A human cardiac transplant: In interim report of a successful operation performed at Groote Schuur Hospital, Cape Town S. Afr. Med. J. 41 1967 1271
3. P.K. Caves E.B. Stinson A.F. Braham et al. Percutaneous transvenous endomyocardial biopsy JAMA 225 1973 288
4. R.N. Pierson III M.L. Barr K.P. McCullough et al. SRTR report on the state of transplantation: Thoracic organ transplantation Am. J. Transplant. 4 Suppl. 9 2004 93
5. J.B. O'Connell R.M. Gunnar R.W. Evans et al. 24th Bethesda conference: cardiac transplantation. Task Force 1: Organization of heart transplantation in the US J. Am. Coll. Cardiol. 22 1993 8
6. L.W. Stevenson Selection and management of the potential candidate for cardiac transplantation In: D.K.C. Cooper L.W. Miller G.A. Patterson, editors. Transplantation and replacement of thoracic organs 2nd ed. 1996 Kluwer Academic Publishers Dordrecht 161-176
7. K.D. Aaronson J.S. Schwartz T.M. Chen et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 1997 2660
8. T.R. Cimato M. Jessup Recipient selection in cardiac transplantation: contraindications and risk factors for mortality J. Heart Lung Transplant. 21 2002 1161
9. D.B. Chomsky C.C. Lang G.H. Rayos et al. Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates Circulation 94 1996 3176
10. J.E. Everett A.R. Djalilian S.H. Kubo et al. Heart transplantation for patients over age 60 Clin. Transplant. 10 6 Pt. 1 1996 478
11. C. Blanche J.J. Takkenberg S. Nessim et al. Heart transplantation in patients 65 years of age and older: A comparative analysis of 40 patients Ann. Thorac. Surg. 62 1996 1442
12. Grover F, chairman. Organ Procurement and Transplantation Network Thoracic Organ Transplantation Committee. Report to the OPTN Board of Directors, June 28-29, 2001, San Diego (Calif).
13. H. Greenberg R.B. Case A.J. Moss et al. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II) J. Am. Coll. Cardiol. 43 2004 1459
14. E.A. Rose A.C. Gelijns A.J. Moskowitz et al. Long-term mechanical left ventricular assistance for end-stage heart failure N. Engl. J. Med. 345 2001 1435
15. A. Zaidi M. Schmoeckel F. Bhatti et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors Transplantation 65 1998 1584
16. M. Schmoeckel F.N. Bhatti A. Zaidi et al. Orthotopic heart transplantation in a transgenic pig-to-primate model Transplantation 65 1998 1570
17. K. Yamada K. Yazawa A. Shimizu et al. Pig-to-baboon life-supporting kidney plus thymus transplantation using GalTK-O donors Am. J. Transplant. 4 Suppl. 8 2004 450 [abstract]
18. H.M. Nathan S.L. Conrad P.J. Held et al. Organ donation in the United States Am. J. Transplant. 3 Suppl. 4 2003 29
19. J.D. Hosenpud L.E. Bennet B.M. Keck et al. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth official report J. Heart Lung Transplant. 18 1999 611
20. V. Jeevanandam S. Furukawa T.W. Prendergast et al. Standard criteria for an acceptable donor heart are restricting heart transplantation Ann. Thorac. Surg. 62 1996 1268
21. D.C. Drinkwater H. Laks A. Blitz et al. Outcomes of patients undergoing transplantation with older donor hearts J. Heart Lung Transplant. 15 1996 684
22. G. Tenderich M.M. Koerner B. Stuettgen et al. Extended donor criteria: hemodynamic follow-up of heart transplant recipients receiving a cardiac allograft from donors ≥60 years of age Transplantation 66 1998 1109
23. K. Lietz R. John D.M. Mancini et al. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list: Implications for donor selection criteria J. Am. Coll. Cardiol. 43 2004 1553
24. J.G. Zaroff B.R. Rosengard W.F. Armstrong et al. Consensus conference report: Maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City (Va) Circulation 106 2002 836
25. S.A. Haji R.C. Starling R.K. Avery et al. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation J. Heart Lung Transplant. 23 2004 277
26. W.J. Ko N.K. Chou R.B. Hsu et al. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area J. Heart Lung Transplant. 20 2001 865
27. G. Opelz Results of cardiac transplantation and factors influencing survival based on the collaborative heart transplant study In: D.K.C. Cooper L.W. Miller G.A. Patterson, editors. Transplantation and replacement of thoracic organs 2nd ed. 1996 Kluwer Academic Publishers Dordrecht 417-427
28. R.N. Pierson III Heart transplantation In: L. Greenfield M. Mulholland, editors. Surgery: Principles and scientific practice 3rd ed. 2001 Lippincott Williams & Wilkins New York 597-608
29. J.D. Vega J.L. Ochsner V. Jeevanandam et al. A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts Ann. Thorac. Surg. 71 2001 1442
30. V. Jeevanandam M.L. Barr J.S. Auteri et al. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial J. Thorac. Cardiovasc. Surg. 103 1992 194
31. A. el Gamel N.A. Yonan S. Grant et al. Orthotopic cardiac transplantation: A comparison of standard and bicaval Wythenshawe techniques J. Thorac. Cardiovasc. Surg. 109 1995 721
32. T. Aziz M. Burgess R. Khafagy et al. Bicaval and standard techniques in orthotopic heart transplantation: Medium-term experience in cardiac performance and survival J. Thorac. Cardiovasc. Surg. 118 1999 115
33. A. Trento J.M. Takkenberg L.S. Czer et al. Clinical experience with one hundred consecutive patients undergoing orthotopic heart transplantation with bicaval and pulmonary venous anastomoses J. Thorac. Cardiovasc. Surg. 112 1996 1496
34. D.K.C. Cooper S. Taniguchi Heterotopic heart transplantation-indications, surgical techniques and special considerations In: D.K.C. Cooper L.W. Miller G.A. Patterson, editors. Transplantation and replacement of thoracic organs 2nd ed. 1996 Kluwer Academic Publishers Dordrecht 353-365
35. O. Tagusari R.L. Kormos A. Kawai et al. Native heart complications after heterotopic heart transplantation: Insight into the potential risk of left ventricular assist device J. Heart Lung Transplant. 18 1999 1111
36. A. Keogh M. Richardson P. Ruygrok et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years. A randomized clinical trial Circulation July 19 2004 [Electronic publication]
37. V.A. Starnes P.E. Oyer E.B. Stinson et al. Prophylactic OKT3 used as induction therapy for heart transplantation Circulation 80 5 Pt. 2 1989 III79
38. J.A. Carey W.H. Frist Use of polyclonal antilymphocytic preparations for prophylaxis in heart transplantation J. Heart Transplant. 9 3 Pt. 2 1990 297
39. K. Lietz R. John A. Beniaminovitz et al. Interleukin-2 receptor blockade in cardiac transplantation: Influence of HLA-DR locus incompatibility on treatment efficacy Transplantation 75 2003 781
40. X.M. Zhao W.H. Frist T.K. Yeoh et al. Modification of alternative messenger RNA splicing of fibroblast growth factor receptors in human cardiac allografts during rejection J. Clin. Invest. 94 1994 992
41. P.J. Michaels M.L. Espejo J. Kobashigawa et al. Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease J. Heart Lung Transplant. 22 2003 58
42. E.F. Reed B. Hong E. Ho et al. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease Transplantation 61 1996 566
43. R.N. Pierson III G.M. Miller Late graft failure: Lessons from clinical and experimental thoracic organ transplantation Graft 3 2000 88
44. C. Schmid U. Heemann N.L. Tilney Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation Transplantation 64 1997 222
45. R.N. Pierson III B.N. Nguyen C. Schroeder et al. Synergism between cCR5 blockade and CsA in primate cardiac allotransplantation J. Heart Lung Transplant. 23 2004 S66
46. B. Hausen R.E. Morris Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies Clin. Chest Med. 16 1997 353
47. J.A. Kobashigawa Statins in solid organ transplantation: Is there an immunosuppressive effect? Am. J. Transplant. 4 2004 1013
48. A.C. Anyanwu C.A. Rogers A.J. Murday et al. Intrathoracic organ transplantation in the United Kingdom 1995-99: Results from the UK cardiothoracic transplant audit Heart 87 2002 449
49. R.W. Evans Socioeconomic aspects of heart transplantation Curr. Opin. Cardiol. 10 1995 169
50. R. Hetzer E.V. Potapov J. Muller et al. Daily noninvasive rejection monitoring improves long-term survival in pediatric heart transplantation Ann. Thorac. Surg. 66 1998 1343
51. S. Borozdenkova J.A. Westbrook V. Patel et al. Use of proteomics to discover novel markers of cardiac allograft rejection J. Proteome Res. 3 2004 282
52. M. Schoels T. Dengler R. Richter et al. Detection of cardiac allograft rejection by realtime PCR analysis of circulating mononuclear cells Clin. Transplant. 18 2004 513
53. K. Christopher T.F. Mueller R. DeFina et al. The graft response to transplantation: A gene expression profile analysis Physiol. Genomics 15 2003 52